Search

everythinglearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 infection may trigger alopecia areata in some patients.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Alopecia areata patients often have other autoimmune diseases, especially women with nail issues or atopic diseases.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

COVID-19 reinfection may trigger alopecia areata.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Alopecia areata treatments often cause headaches and infections, highlighting the need for safer options.

No clear link between androgenetic alopecia and COVID-19 was found.

People with alopecia areata are more likely to get migraines, and vice versa.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Hair loss gene linked to prostate issues.

Hair loss link to severe COVID-19 unclear.

Most kids with alopecia areata have other health issues, often allergies or skin conditions.

Hair loss treatment caused more hair loss in a man.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Removing anthrax toxin receptor 1 in pigs prevents Senecavirus A infection and causes a rare disease similar to GAPO syndrome.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Alopecia Areata is often linked to other health issues like allergies, thyroid problems, and diabetes.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.